Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optive Fusion vs REFRESH PLUS after LASIK
NCT01886690Phase 3Completed
- Sponsor
- Allergan
- Start
- Aug 2013
- Primary completion
- Aug 2014
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of hyaluronic acid sodium salt in dry eye syndrome (DED) (2 arms), sponsored by Allergan. Primary endpoint: Ocular Surface Disease Index at 90 days. Started Aug 2013; status: completed.
02
Drugs
hyaluronic acid sodium salt
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01886690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01886690.